-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Initiates Coverage On Pyxis Oncology with Outperform Rating, Announces Price Target of $6

Benzinga·05/05/2026 13:26:49
Listen to the news
Wedbush analyst Robert Driscoll initiates coverage on Pyxis Oncology (NASDAQ:PYXS) with a Outperform rating and announces Price Target of $6.